The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksHigh Impact•4 March 2026•

1 min read

Vicarious Surgical Faces NYSE Delisting as Trading Suspension Begins

Key Facts

1Vicarious Surgical (RBOT) received a notice from the NYSE that it has commenced the process of delisting the company's Class A common stock.

Vicarious Surgical Inc. (RBOT) has officially received notice that the New York Stock Exchange (NYSE) has commenced proceedings to delist its Class A common stock. The delisting process formally began on March 3, 2026, marking a significant operational setback for the medical robotics company. Such actions by the NYSE are typically triggered when a listed entity fails to maintain minimum requirements, such as share price thresholds or market capitalization standards. Consequently, the company's shares are expected to transition from the main exchange to over-the-counter (OTC) markets. This move is anticipated to result in a substantial reduction in liquidity and a potential decline in investor confidence. Market analysts view this development as highly bearish, given the challenges associated with maintaining valuation and transparency outside of major exchanges.